{"anticipatedPostingDate":"2027-01","denomUnitsSelected":"Participants","description":"Will be summarized with simple summary statistics, including means, medians, ranges, and standard deviations (if numbers and distribution permit).","reportingStatus":"NOT_POSTED","timeFrame":"Pre-dose and 1, 2, 4, and 6-8 hours after dose on cycle 1, day 1; and pre-dose on cycle 1, day 2, and cycle 1, day 15","title":"Preliminary Estimates of the Pharmacokinetics of Ulixertinib in Children and Adolescents With Relapsed or Refractory Cancer","type":"SECONDARY"}